#)18$RS^yw>~ •vvvs7{kxvvF'NTi7j •vvvHL@,exs*+{|1Dvp¢ ¢¡•vvvNTeyb Izxxvvbsw ^y•vvvug-.}bzxxvvvI9fxg- vvv
vvvvvvvvIQwE(w v
vvv
vvBZNTES\`JxwI"/ ¢^yvv

vvvvvvvvvI_~ Xv vt
t6Yv¥;mwn0£4¤uu     vvv
oc[%\`u¥ud £W¤w 0w w3PwOlw
 vovvvvvvvvvvvvvuuu£#w4w<w!w U¤vvvvvvvvvvvvv v£d W¤aZ&)u¥Kw2w\=£h¤ va
vvvvvvvvvvvvvv8 r vPP][\`u¥?3wGw5w VwK
vvvvvvvvvvvvvvP]–wMAq:Cwr@" α   α

!# #

!#  #

 α    α           ! !(&&,')(***,$*+(  "    !

%

ES"')($* 50μm $&%
 ,-+ES cells. /  #*

$*

#*&%
  &%
 &%
#  &%
# 

MSCs

Telomerase  CD105+ cellsTelomerase

DAPI

Merge

CD105

10μm

Telomerase activity ( amol / μL) 0

0.1

0.2

ES Cells
CD105+ MSCs
ADSCs
Blood cells
ES Cells(Heat block) N.D.
CD105+ MSCs
(Heat block)

N.D.

N.D.
ADSCs(Heat block)
Blood cells
N.D.
(Heat block)

Differentiation 2011 132 6 669-672p Nana NinagawaMesenchymal stem cells originating from ES cells show high telomerase activity and therapeutic benefits

DNA microarray     


       
















             

Myogenesis      C2C12

50µm
MSCs

6 days

8 days 

RT-PCR
MyoD

M-cad

 8 days

MHC

 28 days

Myf5Myogenin
M cadherin

50µm

20µm

GAPDH
ES cells Skeletal musclecellsfrom MSCs

! 

'%(&#$" )

*

"



1 

EGFP

300µm

50µm

   

EGFP/M-cad/DAPI

M-cad EGFP    EGFP/MHC/DAPIMHC 

EGFP 



EGFP

MHC



DAPI     %Number%Number%Area%Area-)#$%/12&0*.304Percentage of.load response phaseShamTransplantation

normal leg4%


3Injured leg


(,"
BioReseach Open Access2013 814 2 4 295-306p
Nana Takenaka-Ninagawaa
Transplantation of Mesenchymal Stem Cells Derived
from ES Cells Promotes Muscle Regeneration andAccelerates Functional Recovery of Injured SkeletalMuscle!'+'

55"+(%&'76)5*,$6"19419;  <,47!#,,,,,,,,,,,/:

$6"0283.5-/:%   %       % *24&
HABP  IαI Merge

SHAP-HA

50µm
#'IαI'Hyaluronan-binding protein (HABP)$() *TSG6,TNF -stimulated gene 6product)+!"*
Serum-derived hyaluronan-associated protein (SHAP-HA)&Lysate



TSG6 DAPI +LysatecontAnn

50µm
Real-time PCR**Fold change of comparative ratio 

TSG6 mRNA

108

Control
Lysate +6* ** ** **4

2MSCs

03h6h9h12h

Incubation hours

24h48h**P<0.01
*P<0.05



Lysate TSG6*(TSG6 knockdown (sh mRNA)
EGFP/DAPI

50µm

MSCs/( , "& $*+1. TSG6') "$2. Myotubes* lysate') "$3. Lysate& "$MSCs/ "$ IαI HA SHAP-HA

Area of settled MSCs (mm2)

Cont. +lysateTSG6 KD+lysate**

80706050403020100Con. 8

TSG6 KD

Condition of MSCs**

P<50µm

MSCs+TSG6/"SHAP-HA/!./'"%#-"

<;2>8=?:A@9;.4iPS!%65&!%

B(C12 "#!%)'!%

!%BDC

iPS!%
Transfection oflentivirus(Oct4, Klf4, Sox2, EGFP)

/7

SSEA1BCEGFP DAPI ()EGFP,iPSC

Rat iPSCs

ObeseB$CNanog DAPI+

50µm ALPRat MSCs
Nanog ()

50µm

100µm

LeanB30C

Leptin r

-*
Tuj1 DAPINervous tissues 


Tuj1 DAPI EGFP

10µm

10µm




Mesenchymaltissues

Tuj1 DAPI EGFP

H-E

Collagen II

50µm

50µm

DAPI EGFPCdx2DAPI EGFPEndoderm tissues
50µm

50µm





DAPI MHC

10µm




H-E



Cdx2DAPI#

& 

$" "#

0.8
0.6
0.4
0.2,,
,,

0DS/lean DS/obese

1.2
10.8
0.60.4,
0.2
0PPARγ / GAPDH mRNA

1Adiponectin / GAPDH mRNAPPARγ / GAPDH mRNA

1.2B

1.4

1.4
1.2
10.8
0.60.4,,

0.20

DS/lean DS/obese

iPSCs

Adiponectin / GAPDH mRNA)'(iPS1.4
1.2
10.80.60.4,,

0.20

DS/lean DS/obese

adipose tissue

Real-time PCRLean*%!+
Obese*+3. ES% #$$
AteloCell(Collagen gel)!&

100µm
Flk1

CD105DAPI

Merge

10μm
Stem Cell Discovery 2012 2 2 70-77p Hitomi Hosoe
Investigation of VEGF and PDGF signals in vascular formation by 3D culture models using mouse ES cells"&VEGF1PDGF-B3
-3/9
%
$ &
$
# &
#
" &"
! &!
%&3

30


%&!
%!!
$&!
$!!
#&!
#!!
"&!
"!!
&!
!

**

,+&!!

)!
(!
'!
&!
%!
$!
#!
"!
!

*

,+

*!


PECAM1

**

0;

VEGF+ PDGF B

VEGF+ PDGF B

VEGF+ PDGF B

0



=><

EphrinB2

Flt4

VEGF36

VEGF/7 BDGF-B5

VEGF422.PDGF-B43

2:8

Stem Cell Discovery 201222 70-77p Hitomi Hosoe
Investigation of VEGF and PDGF signals in vascular formation by 3D culture models using mouse ES cells$

4. ES'*C6<#(&'*?
MACSQ"LOJR>AB#( '*?2=/#(@?- ?!%
Islet1TuJ1Islet1Merge;D

100µm

―S
3,)
3U51T1
0U5

PEGNOI#(&'*9D

'*

;D3.+8#(&'*?>7B4

QFHKMER?: 
Nestin 
Tuj1 
Islet1 

Tuj1 Islet1 cont50µm

Real-time PCR
*

*
4.5

*

*

4
3.53

 !   #&+(%*(')+ "$#

no-EF

2.5

4d-DCEF

22d-DCEF

1.5

4d-Pulse

12d-Pulse

0.5

0Islet1mRNA

HB9mRNA

"2,"4
"4 +
"



07

"4$(


$4

#'154"-"&3./6- %) 



*!*!'!68@&& &DBFCE<=PCR

/-1.,-1.13)*>

&;

&&

8@
/+2-0 "$5:?=!(=%(K252a)>!=A79@    

#

&



100nM 500nM 1µM4 